Inspire Medical Systems shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 72 to ...
Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat ...
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 ...
Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...
You don’t realize that you could be sleeping for eight hours but when you get tested you actually only slept for one or two.” ...
Detailed price information for Inspire Medical Systems Inc (INSP-N) from The Globe and Mail including charting and trades.
Inspire Medical Systems, Inc. (NYSE:INSP) is a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea.
ResMed's Chief Medical Officer has suggested doctors will prescribe using both drugs and devices such as his company makes together to help sleep apnea suffers. Shares of ResMed (RMD) and Inspire ...